IMF-WHO COVID-19 Vaccine Tracker

The IMF-WHO COVID-19 Vaccine Tracker builds on the work of the IMF Staff Discussion Note – A Proposal to End the COVID-19 Pandemic (Agarwal and Gopinath, 2021).

This data is preliminary and will be subject to revisions in collaboration with countries and areas, suppliers, immunization, health and financing partners. This tracker is updated every week to reflect latest developments. For additional information or inquiries, please contact vaccinetracker@imf.org.

Vaccine Supply Tracker

IMF-WHO COVID-19 Vaccine Supply Tracker

The IMF-WHO COVID-19 Vaccine Supply Tracker is a comprehensive database jointly established by the IMF and WHO to track the number of vaccine doses secured by countries and areas through different channels, including bilateral agreements with manufacturers, donations from other countries, multilateral agreements through the COVAX Facility, WBG, Asian Development Bank (ADB) or other institutions/sources.

For detailed information regarding data compilation methodology, please see the methodology document here.

The data is available here.

COVAX AMC has ~3.5bn doses as available supply. Until recently, this assessment assumed 30% primary course (2 doses) coverage for AMC countries, however COVAX has not announced an explicit target for 2022. In absence of a clear target, as a rule of thumb we have assumed COVAX will cover at least 40% for AMC91 countries, an additional 10% for LICs, and an additional 10% for fragile and conflict states. This would only sum up to ~2.5bn doses. Such a policy would close much of the procurement gap to 70%, while AVAT supply, bilateral deals and MDB financing can fill in the residual gaps.

Detailed country-level data on the procurement gap to 70% by country can be found here.

Delivery Forecasts

The 70% Vaccination Target: About 61% of the World Received 2+ Doses, but About 130 Countries Did Not Meet the 70% Target by Mid-2022

Prior to June 2022, this tab presented vaccine delivery forecasts and an assessment of whether countries were on track to reach the 70% vaccination target by mid-2022. Now, this tab presents vaccination rates by country at end-June 2022.

Contracts & Donations

IMF-WHO COVID-19 Contracts & Donations Delivery Tracker

The IMF-WHO COVID-19 Contracts & Donations Delivery Tracker tracks the delivery of vaccines by contract, COVAX/AVAT supply, allocation and delivery by product, and vaccines donated/pledged by donor country and product.

1. Country-level Contracts by Manufacturer

Downloadable data can be found here.

Pfizer

Page 1

Page 2

Moderna

Johnson & Johnson

Sputnik V

AstraZeneca - SII

AstraZeneca - Non SII

Bharat

CanSino

Sinopharm

Sinovac

Source: UNICEF Vaccine Market Dashboard, IMF & WHO Staff calculations. Last Update: 2 September 2022

2. COVAX and AVAT Supply

COVAX and AVAT Deliveries

Sources and Notes: COVAX, UNICEF, Africa CDC, IMF staff calculations. Committed doses are doses that the COVAX facility is required to procure. Support from e US has allowed COVAX to secure 1b Pfizer doses. These include a donation of 700m doses, and the rest 300m doses is treated as non-donations. However, for this presentation all 1b facilitated doses are included in the Pfizer category. The secured supply agreement numbers for SII-AstraZeneca and SII-Novavax are approximated based on COVAX Facility candidate-specific supply information. The dose donations are based on COVAX estimates based on commitments from donors to share doses bilaterally with the COVAX facility.

Last Update: 2 September 2022